|
Volumn 43, Issue 2, 2004, Pages 121-124
|
Emergence and clinical significance of YMDD and HBeAg-related mutations during lamivudine treatment
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
P PROTEIN, HEPATITIS B VIRUS;
POL PROTEIN;
ADOLESCENT;
ADULT;
ARTICLE;
FEMALE;
GENETICS;
HEPATITIS B VIRUS;
HEPATITIS C;
HUMAN;
MALE;
MUTATION;
PROTEIN MOTIF;
VIROLOGY;
ADOLESCENT;
ADULT;
AMINO ACID MOTIFS;
ANTIVIRAL AGENTS;
FEMALE;
GENE PRODUCTS, POL;
HEPATITIS B E ANTIGENS;
HEPATITIS B VIRUS;
HEPATITIS C, CHRONIC;
HUMANS;
LAMIVUDINE;
MALE;
MUTATION;
|
EID: 3142739471
PISSN: 05781426
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|